Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.44 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL891074 | 0.99 | MAPT (0.47) | MAPTCYP2C9CYP2C19SMN1; SMN2TDP1 | |
| SCHEMBL14110232 | 0.87 | MAPT (0.57) | MAPTCYP2C9CYP2C19SMN1; SMN2TDP1 | |
| SCHEMBL11464594 | 0.82 | FOLH1 (0.52) | MAPTTDP1L3MBTL1PARP10HTT | |
| SCHEMBL5743109 | 0.81 | FOLH1 (0.57) | MAPTTDP1L3MBTL1PARP10HTT | |
| SCHEMBL6014059 | 0.80 | CTSV (0.48) | MAPTCYP2C9CYP2C19SMN1; SMN2TDP1 | |
| SCHEMBL6358665 | 0.79 | MAOB (0.56) | MAPTTDP1L3MBTL1PARP10HTT | |
| SCHEMBL4346081 | 0.77 | MAPT (0.57) | MAPTSMN1; SMN2L3MBTL1PARP10HTT | |
| SCHEMBL14070590 | 0.76 | MAPT (0.43) | MAPTCYP2C9CYP2C19SMN1; SMN2TDP1 | |
| SCHEMBL15709508 | 0.75 | RXRA (0.54) | MAPTSMN1; SMN2PARP10HTTSMPD1 | |
| SCHEMBL23629037 | 0.75 | PARP10 (0.60) | SMN1; SMN2PARP10PARP1SMPD1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130029901-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | Pradama, Inc. | 2013-01-31 | — | — | US | disclosed |
| US-20130029901-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | Pradama, Inc. | 2013-01-31 | — | — | US | disclosed |
| US-20120083440-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | Pradama, Inc. | 2012-04-05 | — | — | US | disclosed |
| US-20120083440-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | Pradama, Inc. | 2012-04-05 | — | — | US | disclosed |
| US-8071575-B2 | Methods and compounds for the targeted delivery of agents to bone for interaction therewith | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION (US) | 2011-12-06 | — | — | US | disclosed |
| US-8071575-B2 | Methods and compounds for the targeted delivery of agents to bone for interaction therewith | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION (US) | 2011-12-06 | — | — | US | disclosed |
| US-20090118164-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2009-05-07 | — | — | US | disclosed |
| US-20090118164-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2009-05-07 | — | — | US | disclosed |
| WO-2008109780-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC (US) | 2008-09-12 | — | — | WO | disclosed |
| US-20080221070-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2008-09-11 | — | — | US | disclosed |
| US-20080221070-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2008-09-11 | — | — | US | disclosed |
| WO-2008103951-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC (US) | 2008-08-28 | — | — | WO | disclosed |
| US-20070161710-A1 | BONE TARGETING COMPOUNDS FOR DELIVERING AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2007-07-12 | — | — | US | disclosed |
| US-20070161710-A1 | BONE TARGETING COMPOUNDS FOR DELIVERING AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2007-07-12 | — | — | US | disclosed |
| US-7196220-B2 | Bone targeting compounds for delivering agents to the bone for interaction therewith | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2007-03-27 | — | — | US | disclosed |
| US-7196220-B2 | Bone targeting compounds for delivering agents to the bone for interaction therewith | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2007-03-27 | — | — | US | disclosed |
| EP-1697302-A1 | COMPOUNDS FOR DIAGNOSIS, TREATMENT AND PREVENTION OF BONE INJURY AND METABOLIC DISORDERS | University of Louisville Research Foundation (US) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005066114-A1 | COMPOUNDS FOR DIAGNOSIS, TREATMENT AND PREVENTION OF BONE INJURY AND METABOLIC DISORDERS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050143366-A1 | Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | 2005-06-30 | — | — | US | disclosed |
| WO-2000066613-A1 | BONE TARGETING AGENTS FOR OSTEOPOROSIS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2000-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221070-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | SHBG, ESRRA, ESRRG | MAPT 4413/4885CYP2C9 3336/4885CYP2C19 3456/4885 |
| US-20050143366-A1 | Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders | SOST, BMP2, BMP4 | MAPT 3800/4885CYP2C9 2921/4885CYP2C19 2541/4885 |
| US-20120083440-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | BMP2, SOST, BMP4 | MAPT 4451/4885CYP2C9 4717/4885CYP2C19 4805/4885 |
| US-20130029901-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | BMP2, SOST, BMP4 | MAPT 4451/4885CYP2C9 4717/4885CYP2C19 4805/4885 |
| US-20070161710-A1 | BONE TARGETING COMPOUNDS FOR DELIVERING AGENTS TO BONE FOR INTERACTION THEREWITH | SOST, BMP2, BMP6 | MAPT 4393/4885CYP2C9 4533/4885CYP2C19 4413/4885 |
| US-20090118164-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | BMP2, SOST, BMP4 | MAPT 4451/4885CYP2C9 4717/4885CYP2C19 4805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.